Prostate Cancer - Results from #25280

Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: Practice patterns of uro-oncologists in North America - Abstract August 1, 2012

Robustness of ProsVue™ linear slope for prognostic identification of patients at reduced risk for prostate cancer recurrence: Simulation studies on effects of analytical imprecision and sampling time variation - Abstract August 1, 2012

Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer - Abstract August 1, 2012

Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer - Abstract August 1, 2012

A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer - Abstract August 1, 2012

Priapism as the initial manifestation of a penile and lower limb cutaneous metastasis of prostate adenocarcinoma with low serum PSA level: A case report - Abstract August 1, 2012

Factors influencing the degree of enhancement of prostate cancer on contrast-enhanced transrectal ultrasonography: Correlation with biopsy and radical prostatectomy specimens - Abstract August 1, 2012

Therapies used in prostate cancer patients by European urologists: Data on indication with a focus on expectations, perceived barriers and guideline compliance related to the use of bisphosphonates - Abstract August 1, 2012

National comprehensive cancer network practice guidelines 2011: Need for more accurate recommendations for pelvic lymph node dissection in prostate cancer - Abstract August 1, 2012

Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy - Abstract August 1, 2012

The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: Results from a population-based cohort - Abstract July 31, 2012

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro) - Abstract July 31, 2012

Robustness Against Interfraction Prostate Movement in Scanned Ion Beam Radiation Therapy - Abstract July 31, 2012

A Dosimetric Comparison of Tomotherapy and Volumetric Modulated Arc Therapy in the Treatment of High-Risk Prostate Cancer With Pelvic Nodal Radiation Therapy - Abstract July 31, 2012

Hypofractionated High-Dose Radiation Therapy for Prostate Cancer: Long-Term Results of a Multi-Institutional Phase II Trial - Abstract July 31, 2012

Mean Absorbed Dose to the Anal-Sphincter Region and Fecal Leakage among Irradiated Prostate Cancer Survivors - Abstract July 31, 2012

Neoadjuvant Hormone Therapy for Radical Prostate Radiotherapy: Bicalutamide Monotherapy vs. Luteinizing Hormone-Releasing Hormone Agonist Monotherapy: A Single-Institution Matched-Pair Analysis - Abstract July 31, 2012

Evaluation of a Structured Report of Functional Prostate Magnetic Resonance Imaging in Patients with Suspicion for Prostate Cancer or under Active Surveillance - Abstract July 31, 2012

Screening for prostate cancer using multivariate mixed-effects models - Abstract July 31, 2012

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: Implications for focal therapy - Abstract July 31, 2012

Page 1265 of 1436